Search

Stradling

Spectrum Pharmaceuticals, Inc. Acquires Allos Therapeutics, Inc.

Spectrum Pharmaceuticals, Inc.

Represented Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI), in its acquisition of Allos Therapeutics, Inc. for $200 million. 

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in oncology and hematology.